Rabbit monoclonal antibody to group B Streptococcus

Group B Streptococcus (GBS) is found on the skin of many adults and does not usually cause disease. However, when passed to infants at birth, GBS can cause severe disease that can be fatal. This makes it a leading cause of infections in newborns. Fortunately, antibiotic treatment during delivery can protect the baby, and now ViroStat has released a new rabbit monoclonal antibody specific to GBS

The antibody reacts with the GBS Lancefield carbohydrate antigen found on the surface of the bacterium. The antigen can be released from specimens by extraction and detected via immunoassay methods. This new antibody reacts with all GBS strains tested but does not react with other Streptococcus groups. It joins ViroStat’s existing rabbit monoclonal antibody to group A Streptococcus (GAS) as tools for rapid detection.

Data sheets on these new antibodies are available on the ViroStat website.

www.virostat-inc.com

 

 

Other news

Upcoming Events

World Congress of the International Federation of Biomedical Laboratory Science (IFBLS)

Palazza dei Congressi of Firenze
22-26 September 2018

Infection Prevention 2018

Scottish Events Campus, Glasgow
30 September - 2 October 2018

Going Overboard with Microbiology - Women and Children First

Merseyside Maritime Museum, Albert Dock, Liverpool
19 October 2018

Lab Innovations 2018

NEC, Birmingham
31 October - 1 November 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2018

Cryotomy in a Mohs service: the Welsh experience

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.